Table 1 Patient baseline characteristics

Male/female sex n (%)

68/48 (59%/41%)

Age [median (range)]

51 (22–80)

HCV subtype n (%)1a/1b/1a + b

34/77/5 (29%/67%/4%)

HCV-RNA level [median (IQR)] copies/mL

1.8 × 10⁶ (4.5 × 10⁵–6.2 × 10⁶)

AST [median (IQR)] U/L

44 (32–73)

ALT [median (IQR)] U/L

51 (32–93)

γ-GT [median (IQR)] U/L

50 (28–100)

Vitamin B₁₂ [median (IQR)] ng/L

488 (339–727)

Hepatitis activity n (%)

 Mild

79 (68%)

 Moderate/severe

37 (32%)

Fibrosis n (%)

 Absent/mild/moderate

89 (77%)

 Severe/cirrhosis

27 (23%)

Steatosis n (%)

 0–5%

58 (50%)

 6–100%

57 (49%)

 Missing

1 (1%)

IFNL3/IFNL4 rs12979860 n (%)

 CC

44 (38%)

 CT

54 (47%)

 TT

14 (12%)

 Missing

4 (3%)